Your session is about to expire
← Back to Search
Laboratory Biomarker Analysis for Non-Small Cell Lung Cancer
Study Summary
This trial is studying the side effects and best dose of naloxegol for treating patients with stage IIIB-IV non-small cell lung cancer.
- Stage IV Non-small Cell Lung Cancer
- Non-Small Cell Lung Cancer
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What are the anticipated outcomes of this research endeavor?
"This clinical trial seeks to assess the proportion of patients that are alive and continue taking study drug for up to two years, as well as measuring opioid-induced constipation rating scales, unexpected side effects from chemotherapy treatments, and overall survival. Statistical analysis such as Wilcoxon tests, Fisher's exact test, and a Cox proportional hazards model will be used to compare treatment arms vs placebo arm in order to gain further insights into these objectives."
Has this remedy already been studied in other investigations?
"Currently, 3 clinical trials are running to test the efficacy of this treatment. One of these is in its third phase and 666 sites across the nation have been enlisted to run studies on it; notably, many are based out of Columbia, Missouri."
How widespread is the implementation of this trial?
"This trial has 100 open slots across various medical centres like Munson Medical Center in Traverse City, Mitchell Folbe MD PC in Sterling Heights, and Hematology Oncology Consultants-Clarkston in Clarkston. Additionally, there are a number of other sites that also participate."
Are there slots available for participation in this trial?
"Per the clinicaltrials.gov database, this particular study is not accepting any further applicants at this moment in time; it was initially posted on October 13th 2017 and last updated July 11th 2022. Though this trial has closed recruitment, there are 1913 other studies presently recruiting participants."
How many participants are being accepted into this research endeavor?
"This trial is not currently enrolling participants, although it was initially published on October 13th 2017 and last updated July 11th 2022. If you are searching for other studies, there are presently 1910 clinical trials actively recruiting patients with lung cancer as well as 3 active research projects relevant to this medication."
Has this therapeutic option been bestowed regulatory approval by the FDA?
"Our team has given this treatment a safety score of 2, as it is in its Phase 2 trial and there are some indications that the intervention may be safe but insufficient evidence to support efficacy."
Share this study with friends
Copy Link
Messenger